✦ LIBER ✦

Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group

✍ Scribed by Franco M Muggia; John A Blessing; Ramon McGehee; Bradley J Monk

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topotecan in Squamous Cell Carcinoma of

✍ Michael A. Bookman; John A. Blessing; Parviz Hanjani; Thomas J. Herzog; Willie A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Cisplatin plus gemcitabine in previously

✍ Cheryl A. Brewer; John A. Blessing; Robert A. Nagourney; D. Scott McMeekin; Shas 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 91 KB

A phase II trial of pyrazoloacridine (PZ

✍ Steven C. Plaxe; John A. Blessing; George Olt; Nader Husseinzadah; Samuel S. Len 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 71 KB

A Phase II Study of Topotecan in Patient

✍ Laila I. Muderspach; John A. Blessing; Charles Levenback; James L. Moore Jr.; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Cisplatin and Pentoxifylline in Advanced

✍ Robert S. Mannel; John A. Blessing; Guy Boike 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 31 KB

A phase II evaluation of cisplatin and 5

✍ Philip Bonomi; John Blessing; Harrison Ball; Parviz Hanjani; Philip J. DiSaia 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 340 KB